Opportunity ID: 358948

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525MRPSRA
Funding Opportunity Title: DoD Melanoma, Survivorship Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 14, 2025
Last Updated Date: May 23, 2025
Original Closing Date for Applications: Oct 01, 2025
Current Closing Date for Applications: Oct 01, 2025
Archive Date: Oct 31, 2025
Estimated Total Program Funding: $2,030,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families, and/or their caregivers. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health, and/or function are not responsive to this funding opportunity.

Distinctive Features:

·        The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member, and/or caregiver who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization who will be integral to the planning, execution and implementation of the proposed research.

·        Clinical trials are allowed.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date
Pages 4 and 12 of the Program Announcement (PA) have been updated to reflect a change in the funding details from a total direct cost cap to a total cost cap. Additionally the Estimated Total Program Funding amount has been updated in the PA and synopsis. May 23, 2025
corrected the Estimated Total Program Funding total. May 14, 2025
May 14, 2025

DISPLAYING: Synopsis 3

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525MRPSRA
Funding Opportunity Title: DoD Melanoma, Survivorship Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 3
Posted Date: May 14, 2025
Last Updated Date: May 23, 2025
Original Closing Date for Applications: Oct 01, 2025
Current Closing Date for Applications: Oct 01, 2025
Archive Date: Oct 31, 2025
Estimated Total Program Funding: $2,030,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families, and/or their caregivers. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health, and/or function are not responsive to this funding opportunity.

Distinctive Features:

·        The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member, and/or caregiver who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization who will be integral to the planning, execution and implementation of the proposed research.

·        Clinical trials are allowed.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525MRPSRA
Funding Opportunity Title: DoD Melanoma, Survivorship Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: May 14, 2025
Last Updated Date: May 14, 2025
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 01, 2025
Archive Date: Oct 31, 2025
Estimated Total Program Funding: $2,320,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families, and/or their caregivers. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health, and/or function are not responsive to this funding opportunity.

Distinctive Features:

·        The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member, and/or caregiver who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization who will be integral to the planning, execution and implementation of the proposed research.

·        Clinical trials are allowed.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: HT942525MRPSRA
Funding Opportunity Title: DoD Melanoma, Survivorship Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 2
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: May 14, 2025
Last Updated Date: May 14, 2025
Original Closing Date for Applications:
Current Closing Date for Applications: Oct 01, 2025
Archive Date: Oct 31, 2025
Estimated Total Program Funding: $725,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

Summary: Addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families, and/or their caregivers. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health, and/or function are not responsive to this funding opportunity.

Distinctive Features:

·        The application must include at least one melanoma consumer collaborator, defined as a melanoma survivor, family member, and/or caregiver who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization who will be integral to the planning, execution and implementation of the proposed research.

·        Clinical trials are allowed.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Folder 358948 Full Announcement-FY25 MRP SRA -> HT942525MRPSRA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00290734 May 14, 2025 Oct 01, 2025 View

Package 1

Mandatory forms

358948 RR_SF424_5_0-5.0.pdf

358948 AttachmentForm_1_2-1.2.pdf

358948 RR_PersonalData_1_2-1.2.pdf

358948 RR_KeyPersonExpanded_4_0-4.0.pdf

358948 RR_Budget_3_0-3.0.pdf

358948 PerformanceSite_4_0-4.0.pdf

Optional forms

358948 RR_SubawardBudget30_3_0-3.0.pdf

2025-07-14T05:33:11-05:00

Share This Post, Choose Your Platform!

About the Author: